blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3615521

EP3615521 - METHODS FOR IMPROVING MEMORY AND COGNITION AND FOR TREATING MEMORY AND COGNITIVE DISORDERS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  10.05.2024
Database last updated on 20.09.2024
FormerRequest for examination was made
Status updated on  31.01.2020
FormerThe international publication has been made
Status updated on  03.11.2018
Most recent event   Tooltip10.09.2024New entry: Reply to examination report 
Applicant(s)For all designated states
Cavion, Inc.
600 East Water Street, Suite E
Charlottesville, VA 22902 / US
[2020/10]
Inventor(s)01 / MARICICH, Yuri
977 Seminole Trail 357
Charlottesville VA 22901 / US
 [2020/10]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2020/10]
Application number, filing date18791673.926.04.2018
[2020/10]
WO2018US29616
Priority number, dateUS201762490377P26.04.2017         Original published format: US 201762490377 P
[2020/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018200850
Date:01.11.2018
Language:EN
[2018/44]
Type: A1 Application with search report 
No.:EP3615521
Date:04.03.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 01.11.2018 takes the place of the publication of the European patent application.
[2020/10]
Search report(s)International search report - published on:US01.11.2018
(Supplementary) European search report - dispatched on:EP15.01.2021
ClassificationIPC:C07D401/06, C07D413/14, A61K31/44, A61K31/4439, A61K45/06, A61P25/28, C07D207/08, C07D235/14, C07D239/82, C07D213/65
[2021/07]
CPC:
C07D213/65 (EP,IL,KR); A61K31/44 (EP,IL,US); A61K31/4184 (IL,KR);
A61K31/4418 (IL,KR); A61K31/4439 (EP,IL); A61K31/554 (IL,KR);
A61K31/713 (IL,KR); A61K45/06 (EP,IL,KR,US); A61P25/28 (EP,IL,KR,US);
C07D207/08 (EP,IL,KR); C07D235/14 (EP,IL,KR); C07D239/82 (EP,IL,KR);
C07K16/28 (IL,KR); A61K2039/505 (IL,KR) (-)
C-Set:
A61K31/4439, A61K2300/00 (EP);
A61K31/44, A61K2300/00 (EP)
Former IPC [2020/10]C07D401/06, C07D413/14
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/10]
TitleGerman:VERFAHREN ZUR VERBESSERUNG DES GEDÄCHTNISSES UND DER KOGNITION UND ZUR BEHANDLUNG VON GEDÄCHTNIS- UND KOGNITIVEN STÖRUNGEN[2020/10]
English:METHODS FOR IMPROVING MEMORY AND COGNITION AND FOR TREATING MEMORY AND COGNITIVE DISORDERS[2020/10]
French:PROCÉDÉS D'AMÉLIORATION DE LA MÉMOIRE ET DE LA COGNITION, ET DE TRAITEMENT DES TROUBLES DE LA MÉMOIRE ET DES TROUBLES COGNITIFS[2020/10]
Entry into regional phase22.11.2019National basic fee paid 
22.11.2019Search fee paid 
22.11.2019Designation fee(s) paid 
22.11.2019Examination fee paid 
Examination procedure22.11.2019Examination requested  [2020/10]
12.08.2021Amendment by applicant (claims and/or description)
10.05.2024Despatch of a communication from the examining division (Time limit: M04)
10.09.2024Reply to a communication from the examining division
Fees paidRenewal fee
27.04.2020Renewal fee patent year 03
15.04.2021Renewal fee patent year 04
20.03.2022Renewal fee patent year 05
14.03.2023Renewal fee patent year 06
13.03.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2006098969  (MERCK & CO INC [US], et al) [X] 1-9,11,21,22 * page 2, line 8 - line 13 * * page 14, line 23 - line 32 * * claims 1, 26,27 *;
 [X]KR20090044924  (KOREA INST SCI & TECH [KR]) [X] 1-9,11 * paragraph [0110] *;
 [X]WO2009133128  (PHARNEXT [FR], et al) [X] 1-9,18,21,22 * claims 1, 18, 19 *;
 [XI]US2010137403  (MALSTROM SCOTT [US], et al) [X] 1-9,11,18,21 * claims 1, 2, 11 * * claim 28 * [I] 10,12-17,19,20,22;
 [XP]WO2017070680  (CAVION LLC [US]) [XP] 1-22 * claims 1-51 *;
 [E]WO2019175395  (FISAHN ANDRE [SE], et al) [E] 1-22 * claims 1, 6 * * claim 18 *;
 [A]  - ZIXIU XIANG ET AL, "The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson's Disease", ACS CHEMICAL NEUROSCIENCE, US, (20111028), vol. 2, no. 12, doi:10.1021/cn200090z, ISSN 1948-7193, pages 730 - 742, XP055761082 [A] 1-22 * compound 9; page 732; figure 2 *

DOI:   http://dx.doi.org/10.1021/cn200090z
International search[A]US2010216841  (BARROW JAMES C [US], et al) [A] 1-3 * ; entire document *;
 [X]WO2012094615  (ZENYAKU KOGYO KK [JP], et al) [X] 1-3 * ; para [0001], [0018], [0088]-[0089] *;
 [A]US8586619  (WU JAY JIE-QIANG [US], et al) [A] 1-3 * ; entire document *;
 [PX]WO2017070680  (CAVION LLC [US]) [PX] 1-3* ; entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.